Figure 4.
24 h steady-state concentration profiles of IBR, DIB, and the active moiety (IBR + DIB) in three chronic lymphocyte leukemia patients taking 420 mg (Subjects I and II) or 280 mg (Subject III) IBR per day.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.